240 related articles for article (PubMed ID: 27046157)
1. Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression.
Lei Y; Hamada Y; Li J; Cong L; Wang N; Li Y; Zheng W; Jiang X
J Control Release; 2016 Jun; 232():131-42. PubMed ID: 27046157
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug.
Jiang X; Fan X; Xu W; Zhao C; Wu H; Zhang R; Wu G
J Control Release; 2019 Dec; 316():196-207. PubMed ID: 31682910
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer.
Etman SM; Abdallah OY; Mehanna RA; Elnaggar YSR
Int J Pharm; 2020 Mar; 578():119097. PubMed ID: 32032904
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
[TBL] [Abstract][Full Text] [Related]
8. Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles.
Qian C; Wang Y; Chen Y; Zeng L; Zhang Q; Shuai X; Huang K
Biomaterials; 2013 Aug; 34(26):6175-84. PubMed ID: 23721794
[TBL] [Abstract][Full Text] [Related]
9. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
10. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
Mou Q; Ma Y; Zhu X; Yan D
J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer.
He YJ; Xing L; Cui PF; Zhang JL; Zhu Y; Qiao JB; Lyu JY; Zhang M; Luo CQ; Zhou YX; Lu N; Jiang HL
Biomaterials; 2017 Jan; 113():266-278. PubMed ID: 27842254
[TBL] [Abstract][Full Text] [Related]
12. Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer.
Daman Z; Faghihi H; Montazeri H
Drug Dev Ind Pharm; 2018 Sep; 44(9):1434-1442. PubMed ID: 29619850
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
14. Tumor-microenvironment controlled nanomicelles with AIE property for boosting cancer therapy and apoptosis monitoring.
Qian Y; Wang Y; Jia F; Wang Z; Yue C; Zhang W; Hu Z; Wang W
Biomaterials; 2019 Jan; 188():96-106. PubMed ID: 30339943
[TBL] [Abstract][Full Text] [Related]
15. Multistimuli-Regulated Photochemothermal Cancer Therapy Remotely Controlled via Fe5C2 Nanoparticles.
Yu J; Ju Y; Zhao L; Chu X; Yang W; Tian Y; Sheng F; Lin J; Liu F; Dong Y; Hou Y
ACS Nano; 2016 Jan; 10(1):159-69. PubMed ID: 26602632
[TBL] [Abstract][Full Text] [Related]
16. Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery.
Min HS; Son S; You DG; Lee TW; Lee J; Lee S; Yhee JY; Lee J; Han MH; Park JH; Kim SH; Choi K; Park K; Kim K; Kwon IC
Biomaterials; 2016 Nov; 108():57-70. PubMed ID: 27619240
[TBL] [Abstract][Full Text] [Related]
17. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
19. Smart surface coating of drug nanoparticles with cross-linkable polyethylene glycol for bio-responsive and highly efficient drug delivery.
Wei W; Zhang X; Chen X; Zhou M; Xu R; Zhang X
Nanoscale; 2016 Apr; 8(15):8118-25. PubMed ID: 27025546
[TBL] [Abstract][Full Text] [Related]
20. Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness.
Fracasso G; Falvo E; Colotti G; Fazi F; Ingegnere T; Amalfitano A; Doglietto GB; Alfieri S; Boffi A; Morea V; Conti G; Tremante E; Giacomini P; Arcovito A; Ceci P
J Control Release; 2016 Oct; 239():10-8. PubMed ID: 27524282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]